首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal CDRT15L2 Antibody

  • 中文名: CDRT15L2抗体
  • 别    名: nan
货号: IPDX13053
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human CDRT15L2
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

关于CDRT15L2抗体的研究目前公开的文献较为有限,以下为假设性示例(实际文献需通过学术数据库验证):

1. **文献名称**: *Characterization of CDRT15L2 as a novel tumor-associated antigen*

**作者**: Smith A, et al.

**摘要**: 该研究首次报道了CDRT15L2蛋白在多种癌症中的异常表达,并开发了针对该蛋白的小鼠单克隆抗体。实验验证了抗体在Western blot和免疫组化中的特异性,提示其作为诊断标志物的潜力。

2. **文献名称**: *CDRT15L2 antibody-mediated targeting in colorectal cancer therapy*

**作者**: Lee B, et al.

**摘要**: 研究利用人源化CDRT15L2抗体进行体外和体内实验,证明其通过ADCC效应抑制结直肠癌细胞增殖,并显著降低小鼠移植瘤模型中的肿瘤体积。

3. **文献名称**: *Epigenetic regulation of CDRT15L2 and antibody-based detection in liquid biopsies*

**作者**: Zhang C, et al.

**摘要**: 揭示了CDRT15L2启动子甲基化与基因沉默的关系,并开发了高灵敏度ELISA检测方法,证实其在肺癌患者血液样本中的诊断价值。

4. **文献名称**: *Comparative analysis of CDRT15L2 antibody clones for flow cytometry applications*

**作者**: Gupta R, et al.

**摘要**: 系统比较了4种商业CDRT15L2抗体的性能,确定Clone 3F8在流式细胞术中具有最佳信噪比,适用于免疫细胞亚群分析。

---

**建议**:

1. 实际研究中请通过PubMed、Web of Science等平台,以“CDRT15L2 antibody”或“CDRT15L2 + [技术/疾病]”为关键词检索最新文献。

2. 若靶点为罕见或新命名基因,建议查阅相关专利数据库(如Google Patents)或联系抗体供应商获取技术资料。

背景信息

The CDRT15L2 antibody is a monoclonal antibody primarily used in research to detect the CDRT15L2 protein, a poorly characterized antigen with potential roles in cellular signaling or disease pathways. Although limited public data exists, CDRT15L2 is speculated to belong to a family of proteins involved in membrane-associated processes, possibly linked to neurological disorders or cancer progression. This antibody is commonly employed in immunohistochemistry (IHC), Western blotting, and immunofluorescence to localize and quantify CDRT15L2 expression in tissue samples or cell lines. Its development likely stems from interest in identifying novel biomarkers or therapeutic targets, particularly in oncology, where aberrant protein expression patterns may correlate with tumor aggressiveness or drug resistance. The antibody’s immunogen, host species (often rabbit or mouse), and specific epitope remain undisclosed in public databases, highlighting the need for further validation studies. Researchers utilize CDRT15L2 antibody to explore its involvement in cellular functions such as adhesion, proliferation, or apoptosis, though conclusive mechanistic insights are still pending. Commercial availability through niche biotech suppliers suggests specialized applications, urging users to verify cross-reactivity and optimize protocols for experimental reproducibility.

客户数据及评论

折叠内容

大包装询价

×